Replies to post #756077 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

There is no documentation or evidence for any RA to require Eden 

[flipper44]

Again, Linda Powers and all relevant filings state we are starting with commercial artisan, and Eden (commercial version unit) will then undergo comparability testing prior to commercial certification.

[martyDg]

Keep pushing the regulator waiting for EDEN narrative!

[georgebailey]

See below DI response to investor Tom - DI says there are TWO top priorities pending a decision.
If the MHRA is one, what is the second pending decision? IS nGBM + rGBM = the two priorities?

$nwbo @alphavestcap @hoffmann6383 @BrianEgolf2 https://t.co/MrYuq2N2Rihttps://t.co/uJ75cuE5g0

1) "The Company completed negotiations and entered into a contract with a company that has a complementary immunotherapy agent, and the two companies have been engaged for a number… pic.twitter.com/8zL2olhM9B

— alphavestcapital.com (@alphavestcap) March 24, 2025